References
SPRINT Research Group, Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. doi:10.1056/NEJMoa1511939.
Flack JM, Nolasco C, Levy P. The case for low blood pressure targets. Am J Hypertens. 2017;30:3–7.
Ference BA, Julius S, Mahajan N, Levy PD, Williams KA, Flack JM. Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension. Hypertension. 2014;63(6):1182–8. doi:10.1161/HYPERTENSIONAHA.113.02734.
Liu K, Colangelo LA, Daviglus ML, Goff DC, Pletcher M, Schreiner PJ, et al. Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels?: the Coronary Artery Risk Development in Young Adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc. 2015;4(9):e002275. doi:10.1161/JAHA.115.002275.
Bakris GL. The implications of blood pressure measurement methods on treatment targets for blood pressure. Circulation. 2016;134(13):904–5. doi:10.1161/CIRCULATIONAHA.116.022536. Epub 2016 Aug 30
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Flack declares no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Rights and permissions
About this article
Cite this article
Flack, J.M. Method of Blood Pressure Measurement, Interpretation of SPRINT, and the Atlantic Divide. Curr Hypertens Rep 19, 19 (2017). https://doi.org/10.1007/s11906-017-0719-0
Published:
DOI: https://doi.org/10.1007/s11906-017-0719-0